NRx Pharmaceuticals (NRXP)
(Delayed Data from NSDQ)
$2.52 USD
+0.06 (2.44%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $2.55 +0.03 (1.19%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, NRx Pharmaceuticals, Inc. has a market cap of $42.53M, which represents its share price of $2.46 multiplied by its outstanding shares number of 17.29M. As a small-cap company, NRXP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NRXP 2.52 +0.06(2.44%)
Will NRXP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NRXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NRXP
Here's Why NRx Pharmaceuticals (NRXP) Is a Great 'Buy the Bottom' Stock Now
NRx Pharmaceuticals to Post Q4 Earnings: How to Play the Stock?
NRXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Momentum Stocks to Buy for January 6th
New Strong Buy Stocks for January 6th
Best Momentum Stocks to Buy for December 30th
Other News for NRXP
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. ...
HOPE Therapeutics, NRx Pharmaceuticals cleared to close Dura Medical acquisition
NRXP: Analyst Jason Kolbert Maintains 'Buy' Rating at $31.00 | NRXP Stock News
NRx Pharmaceuticals (NRXP) Seeks FDA Action on Ketamine Preservative
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food ...